SCHEMBL6562572

SCHEMBL6562572

Brc1ccc(-c2ccc(Br)c(-c3ccccc3)c2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.62
MAPK1 P28482 2/20 0.62
NPC1 O15118 3/20 0.47
RAB9A P51151 3/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
MAPT P10636 2/20 0.47
MEN1 O00255 1/20 0.47
APAF1 O14727 1/20 0.47
LMNA P02545 1/20 0.47
THRB P10828 1/20 0.47
XBP1 P17861 1/20 0.47
PTBP1 P26599 1/20 0.47
HTT P42858 1/20 0.47
GALK1 P51570 1/20 0.47
BLM P54132 1/20 0.47
SMAD3 P84022 1/20 0.47
KMT2A Q03164 1/20 0.47
ATM Q13315 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20955794 0.94 ALDH1A1 (0.58) ALDH1A1MAPK1NPC1RAB9ASMN1; SMN2
SCHEMBL3748766 0.94 ALDH1A1 (0.58) ALDH1A1MAPK1NPC1RAB9ASMN1; SMN2
SCHEMBL31512408 0.85 ALDH1A1 (0.65) ALDH1A1MAPK1NPC1RAB9ASMN1; SMN2
SCHEMBL29450690 0.85 ALDH1A1 (0.65) ALDH1A1MAPK1NPC1RAB9ASMN1; SMN2
SCHEMBL17539981 0.85 ALDH1A1 (0.65) ALDH1A1MAPK1NPC1RAB9ASMN1; SMN2
SCHEMBL24123167 0.85 ALDH1A1 (0.65) ALDH1A1MAPK1NPC1RAB9ASMN1; SMN2
SCHEMBL2713867 0.85 ALDH1A1 (0.65) ALDH1A1MAPK1NPC1RAB9ASMN1; SMN2
SCHEMBL18050369 0.85 ALDH1A1 (0.65) ALDH1A1MAPK1NPC1RAB9ASMN1; SMN2
SCHEMBL25629333 0.85 ALDH1A1 (0.65) ALDH1A1MAPK1NPC1RAB9ASMN1; SMN2
SCHEMBL3007914 0.85 MAPK1 (0.58) ALDH1A1MAPK1NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10276800-B2 Organic electroluminescence device having at least an a node, a hole injection layer, a first hole transport layer. A second hole transport layer a luminous layer, an electron transport layer, and a cathode HODOGAYA CHEMICAL CO., LTD. (JP) 2019-04-30 US disclosed
US-20170317291-A1 ORGANIC ELECTROLUMINESCENCE DEVICE HODOGAYA CHEMICAL CO., LTD. (JP) 2017-11-02 US disclosed
EP-1122746-B1 Composition for film formation and insulating film JSR CORP (JP) 2004-09-22 EP disclosed
US-6468589-B2 A HEAT-CURED POLYETHER BASED ON A 9,9-BIS(P-HYDROXYPHENYL)-FLUORENE HAVING AT LEAST ONE ALKYL SUBSTITUENT AND A DIHYDROXY AROMATIC COMONOMER; LOW DIELECTRIC PROTECTIVE COATINGS; HEAT RESISTANCE; NONCRACKING JSR CORPORATION (JP) 2002-10-22 US disclosed
US-20010012870-A1 Composition for film formation and insulating film JSR CORPORATION (JP) 2001-08-09 US disclosed
EP-1122746-A1 Composition for film formation and insulating film JSR Corporation (JP) 2001-08-08 EP disclosed
US-4143077-A BROMINATING, THEN IODINATING M-TERPHENYL, ETHERIFYING WITH AN ALKALI METAL PHENOLATE INSTITUT FRANCAIS DU PETROLE (FR) 1979-03-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10276800-B2 Organic electroluminescence device having at least an a node, a hole injection layer, a first hole transport layer. A second hole transport layer a luminous layer, an electron transport layer, and a cathode SLC29A1, SLC29A2, NUDT1 ALDH1A1 776/4885MAPK1 1431/4885NPC1 799/4885
US-20170317291-A1 ORGANIC ELECTROLUMINESCENCE DEVICE NUDT1, SLCO4C1, SLC7A5 ALDH1A1 633/4885MAPK1 1777/4885NPC1 1126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.